학술논문
Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)
Document Type
Article
Author
Source
In Growth Hormone & IGF Research October 2017 36:11-15
Subject
Language
ISSN
1096-6374